Results 241 to 246 of about 37,931 (246)

Autosomal dominant polycystic kidney disease

Drugs of the Future, 2006
Autosomal dominant polycystic kidney disease (ADPKD) is the most common form of polycystic kidney diseases, which are genetic disorders characterized by the abnormal growth of numerous cysts in the kidneys. ADPKD is one of the leading causes of end-stage renal failure.
Jordi Bozzo, Elisa Ferrer
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Polycystic Kidney, Autosomal Dominant, Date of authorisation: 27/05/2015, Revision: 11, Status: Authorised

Case Medical Research, 2019

semanticscholar   +1 more source

Autosomal dominant polycystic kidney disease.

American Family Physician, 2014
A. Srivastava, Neel Patel
semanticscholar   +1 more source

Massive autosomal dominant polycystic kidneys

Urology, 2001
David A. Goldfarb, Thomas H.S. Hsu
openaire   +3 more sources

Choledocholithiasis in autosomal dominant polycystic kidney disease

Digestive and Liver Disease, 2021
Sanjeev Sachdeva, Sukrit Singh Sethi, Ajay Kumar, Ashok Dalal   +3 more
openaire   +3 more sources

Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease

Drugs, 2019
Hannah A. Blair
semanticscholar   +1 more source